1. Home
  2. LUNG vs TATT Comparison

LUNG vs TATT Comparison

Compare LUNG & TATT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LUNG
  • TATT
  • Stock Information
  • Founded
  • LUNG 1995
  • TATT 1985
  • Country
  • LUNG United States
  • TATT Israel
  • Employees
  • LUNG N/A
  • TATT N/A
  • Industry
  • LUNG Industrial Specialties
  • TATT Aerospace
  • Sector
  • LUNG Health Care
  • TATT Industrials
  • Exchange
  • LUNG Nasdaq
  • TATT Nasdaq
  • Market Cap
  • LUNG 124.0M
  • TATT 379.0M
  • IPO Year
  • LUNG 2020
  • TATT 1987
  • Fundamental
  • Price
  • LUNG $2.87
  • TATT $29.63
  • Analyst Decision
  • LUNG Buy
  • TATT Strong Buy
  • Analyst Count
  • LUNG 6
  • TATT 3
  • Target Price
  • LUNG $11.53
  • TATT $36.00
  • AVG Volume (30 Days)
  • LUNG 317.8K
  • TATT 210.4K
  • Earning Date
  • LUNG 07-30-2025
  • TATT 08-27-2025
  • Dividend Yield
  • LUNG N/A
  • TATT N/A
  • EPS Growth
  • LUNG N/A
  • TATT 81.73
  • EPS
  • LUNG N/A
  • TATT 1.14
  • Revenue
  • LUNG $87,473,000.00
  • TATT $160,170,000.00
  • Revenue This Year
  • LUNG $18.02
  • TATT $18.62
  • Revenue Next Year
  • LUNG $18.17
  • TATT $10.62
  • P/E Ratio
  • LUNG N/A
  • TATT $26.40
  • Revenue Growth
  • LUNG 19.84
  • TATT 30.57
  • 52 Week Low
  • LUNG $2.50
  • TATT $12.61
  • 52 Week High
  • LUNG $9.37
  • TATT $36.49
  • Technical
  • Relative Strength Index (RSI)
  • LUNG 39.07
  • TATT 54.93
  • Support Level
  • LUNG $2.62
  • TATT $30.01
  • Resistance Level
  • LUNG $2.88
  • TATT $31.86
  • Average True Range (ATR)
  • LUNG 0.17
  • TATT 1.46
  • MACD
  • LUNG 0.05
  • TATT 0.29
  • Stochastic Oscillator
  • LUNG 39.68
  • TATT 73.73

About LUNG Pulmonx Corporation

Pulmonx Corp is a commercial-stage medical technology company. It provides a minimally invasive treatment for patients with severe emphysema, a form of chronic obstructive pulmonary disease (COPD). The company's solutions are comprised of the Zephyr Endobronchial Valve, the Chartis Pulmonary Assessment System and the StratX Lung Analysis Platform. It generates revenue through the sale of products to distributors and hospitals in the United States which a key revenue generating market, Europe, Middle-East and Africa, Asia Pacific and other regions.

About TATT TAT Technologies Ltd.

TAT Technologies Ltd provides solutions and services to the commercial and military aerospace and ground defense industries, focused mainly on three product areas and services: Thermal Management, Power and Actuation, and Maintenance, Repair and Overhaul (MRO). Its product portfolio includes heat exchangers, cooling systems, and mechanical aircraft accessories and systems such as pumps, valves, and turbine power units. Its operating segments are MRO services for aviation components, which derive key revenue, Original equipment manufacturing (OEM) of heat transfer solutions and aviation accessories, MRO services for heat transfer components and OEM of heat transfer solutions, and Overhaul and coating of jet engine components. Geographically, it derives key revenue from the United States.

Share on Social Networks: